+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter, open-label assessment of the efficacy and safety of zonisamide as adjunctive therapy for primary generalized epilepsy

Multicenter, open-label assessment of the efficacy and safety of zonisamide as adjunctive therapy for primary generalized epilepsy

Epilepsia 43(Supplement 7): 190

(PDF 0-2 workdays service: $29.90)

Accession: 035349975

Download citation: RISBibTeXText

Related references

Multicenter, open-label, safety and efficacy study of zonisamide in patients with progressive myoclonic epilepsy. Neurology 58(7 Supplement 3): A296-A297, April 9, 2002

Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients. Seizure 21(3): 188-193, 2012

Safety and efficacy of zonisamide as adjunctive therapy for refractory complex partial seizures An open label study. Epilepsia 41(Supplement 7): 225-226, 2000

The safety and long-term efficacy of zonisamide as adjunctive therapy for focal epilepsy. Expert Review of Neurotherapeutics 15(8): 857-865, 2016

Efficacy and safety of levetiracetam as adjunctive therapy in Japanese children with uncontrolled partial-onset seizures: multicenter and open-label study (N01223), short term evaluation. Brain and Nerve 65(9): 1083-1092, 2014

Safety of 25- and 50-mg capsules in the initiation of zonisamide therapy in patients with epilepsy: an uncontrolled, open-label study. Current Medical Research and Opinion 20(6): 837-842, 2004

Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study. Epilepsy Research 103(2-3): 262-269, 2013

Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial. Epilepsia 55(4): 568-578, 2014

A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma. Archives of Ophthalmology 122(7): 957-965, 2004

Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study. Epilepsia 53(1): 111-119, 2012

Two open-label, multicenter studies of the safety and efficacy of gabapentin in patients with refractory epilepsy. Epilepsia 33(SUPPL 3): 77, 1992

Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study. Epilepsy Research 83(2-3): 112-116, 2009

Efficacy and safety of ucbL059 as an adjunctive treatment in refractory partial epilepsy Results of open-label treatment at two centers. Epilepsia 37(SUPPL 5): 169, 1996

Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study. Journal of Dermatology 43(9): 1011-1017, 2016

Zonisamide efficacy as adjunctive therapy in children with refractory epilepsy. Iranian Journal of Child Neurology 7(2): 37-42, 2014